Terumo BCT to Showcase Scaling Cell Therapy Manufacturing Case Studies

Share Article

In this webinar, which LabRoots will host May 31, attendees will gain insights into T-cell expansion, viral vector production and scaling production of mesenchymal stem cells through the use of a functionally closed, automated, cell culture process.

Jim Beltzer, PhD Senior Cell Processing Specialist, Terumo BCT

Throughout this webinar, participants will learn from a number of Terumo BCT case studies, describing how process development and economic goals were achieved in both industry and academic settings. Attendees will learn from new results of T-cell expansion using a hollow-fiber bioreactor system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and new approach to viral vector production.

Results include up to a 500-fold expansion of T-cells in 12 days, 40 percent reduction in cost of goods (COGs) of growing cells for an allogeneic therapy, and automated viral vector production with titers similar to flask-based processes. Particular attention will be directed toward the process changes often needed to meet these goals.

The speaker for this event will be Dr. Jim Beltzer, senior cell Processing specialist at Terumo BCT. Beltzer earned a doctorate in biochemistry from the Purdue University. Prior to joining Terumo BCT, Beltzer was the lead scientist for the research and development of Corning® Synthemax®, a synthetic growth surface for the culture of human embryonic stem cells at Corning Life Sciences. He was a co-founder of RETT Corporation and was a key player in the industrialization of several technology platforms.

LabRoots will host this even May 31, 2017, beginning at 6:00 p.m. PDT, 9:00 a.m. SGT, 12:00 p.m. AEDT. To read more about this event, learn of the continuing education credits offered, or to register for free, click here.

ABOUT TERUMO BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.

ABOUT LABROOTS
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website